Showing results (131-140 of 157) with videos related to
Sort By:
Pageof 16
Pathologie (Heidelberg, Germany)|November 26, 2025
POLQ and DNA-PK inhibition in muscle-invasive bladder cancer : Enhancing radiosensitivity with novel DNA damage response inhibitors to improve radiotherapy outcomesJulia Pannhausen, Ahmed A Chughtai, Michael K Melzer, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2012
Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II studyM D Piroth, M Pinkawa, R Holy, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 5, 2006
Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I studyBernd Gagel, Marc Piroth, Michael Pinkawa, et al.Nuclear Medicine and Biology|June 18, 2013
Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomasMarc D Piroth, Jeyakamalini Prasath, Antje Willuweit, et al.BMC Cancer|March 7, 2006
[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility studyBernd Gagel, Patrick Reinartz, Cengiz Demirel, et al.International Journal of Radiation Oncology, Biology, Physics|February 19, 2013
A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomesDanny Y Song, Klaus K Herfarth, Matthias Uhl, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 31, 2012
Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRINorbert Galldiks, Karl-Josef Langen, Richard Holy, et al.Journal of Thoracic Disease|December 23, 2017
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy"Juliane Hoerner-Rieber, Marciana Duma, Oliver Blanck, et al.Clinical and Translational Radiation Oncology|December 3, 2024
The prognostic utility of IGF-1 in hepatocellular carcinoma treated with stereotactic body radiotherapyAhmed Allam Mohamed, Cennet Sahin, Marie-Luise Berres, et al.Academic Pediatrics|February 13, 2026
Conscientious Objection to Gender-Affirming Care in U.S. Pediatric ResidenciesDanielle J Eble, Alisha L Nguyen, Cole V Roblee, et al.Pageof 16